NO873298L - Oralt terapeutisk system med systematisk virkning. - Google Patents

Oralt terapeutisk system med systematisk virkning.

Info

Publication number
NO873298L
NO873298L NO87873298A NO873298A NO873298L NO 873298 L NO873298 L NO 873298L NO 87873298 A NO87873298 A NO 87873298A NO 873298 A NO873298 A NO 873298A NO 873298 L NO873298 L NO 873298L
Authority
NO
Norway
Prior art keywords
therapeutic system
oral therapeutic
systematic effect
systematic
effect
Prior art date
Application number
NO87873298A
Other languages
English (en)
Other versions
NO173726B (no
NO873298D0 (no
NO173726C (no
Inventor
Satish Chandra Khanna
Theresa Ruttimann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO873298D0 publication Critical patent/NO873298D0/no
Publication of NO873298L publication Critical patent/NO873298L/no
Publication of NO173726B publication Critical patent/NO173726B/no
Publication of NO173726C publication Critical patent/NO173726C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
NO873298A 1986-08-07 1987-08-06 Fremgangsmaate for fremstilling av et oralt terapeutisk system for administrering av karbamazpin NO173726C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH3172/86A CH668187A5 (de) 1986-08-07 1986-08-07 Therapeutisches system mit systemischer wirkung.

Publications (4)

Publication Number Publication Date
NO873298D0 NO873298D0 (no) 1987-08-06
NO873298L true NO873298L (no) 1988-02-08
NO173726B NO173726B (no) 1993-10-18
NO173726C NO173726C (no) 1994-01-26

Family

ID=4250176

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873298A NO173726C (no) 1986-08-07 1987-08-06 Fremgangsmaate for fremstilling av et oralt terapeutisk system for administrering av karbamazpin

Country Status (30)

Country Link
US (1) US4857336A (no)
JP (1) JP2592460B2 (no)
KR (1) KR950006219B1 (no)
AT (1) AT397344B (no)
AU (1) AU597403B2 (no)
BE (1) BE1000235A3 (no)
CA (1) CA1302267C (no)
CH (1) CH668187A5 (no)
DD (1) DD285718A5 (no)
DE (1) DE3725824C2 (no)
DK (1) DK175497B1 (no)
ES (1) ES2007100A6 (no)
FI (1) FI86143C (no)
FR (1) FR2602425B1 (no)
GB (1) GB2193632B (no)
GR (1) GR871234B (no)
HK (1) HK33793A (no)
HU (1) HU206978B (no)
IE (1) IE59718B1 (no)
IL (1) IL83386A (no)
IT (1) IT1215618B (no)
LU (1) LU86966A1 (no)
MY (1) MY100767A (no)
NL (1) NL194780C (no)
NO (1) NO173726C (no)
NZ (1) NZ221347A (no)
PH (1) PH25090A (no)
PT (1) PT85489B (no)
SE (1) SE502590C2 (no)
ZA (1) ZA875804B (no)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2039287T3 (es) * 1987-01-14 1993-09-16 Ciba-Geigy Ag Procedimiento para la obtencion de un sistema terapeutico peroral para productos activos dificilmente solubles.
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
NZ226179A (en) * 1987-09-24 1991-04-26 Merck & Co Inc Controlled porosity osmotic pump for sustained release of pharmaceutical agents
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
WO1992012633A1 (en) * 1991-01-16 1992-08-06 Fmc Corporation Carrier for active agents, and solid dosage forms prepared therewith
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US20040191314A1 (en) * 1994-04-28 2004-09-30 Frank Jao Antiepileptic dosage form and process for protecting antiepileptic drug
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
DE4423078B4 (de) 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US5980942A (en) * 1997-01-23 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release matrix tablet formulations of carbamazepine
US6296873B1 (en) 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
PL192273B1 (pl) 1997-09-25 2006-09-29 Bayer Ag Preparat środka leczniczego w postaci pastylki o kontrolowanej dyfuzji lub w postaci układu matrycowego, o kontrolowanym uwalnianiu substancji czynnej
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
PT1079813E (pt) * 1998-04-29 2005-05-31 Virotex Corp Dispositivo transportador farmaceutico adequado para entrega de compostos farmaceuticos as superficies mucosas
US6706283B1 (en) 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
US7964216B2 (en) * 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
IN190699B (no) * 2001-02-02 2003-08-16 Sun Pharmaceutical Ind Ltd
EP1377276B1 (en) * 2001-04-10 2011-10-05 Sun Pharma Advanced Research Company Limited Timed pulse release composition
US20030161882A1 (en) * 2002-02-01 2003-08-28 Waterman Kenneth C. Osmotic delivery system
TW200302748A (en) * 2002-02-01 2003-08-16 Pfizer Prod Inc Osmotic delivery system
US6572889B1 (en) 2002-03-07 2003-06-03 Noveon Ip Holdings Corp. Controlled release solid dosage carbamazepine formulations
AU2003231919A1 (en) * 2002-03-14 2003-09-22 Sun Pharmaceutical Industries Limited Oral controlled drug delivery system containing carbamazepine
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
EP1690540A1 (en) * 2005-02-15 2006-08-16 Neuro3D Composition comprising ocaperidone
US20060275367A1 (en) * 2005-04-25 2006-12-07 Shubha Chungi Extended release formulations
US20070071819A1 (en) * 2005-05-30 2007-03-29 Kesarwani Amit K Multiple unit modified release compositions of carbamazepine and process for their preparation
KR101329496B1 (ko) 2006-07-21 2013-11-13 바이오딜리버리 사이언시스 인터내셔널 인코포레이티드 향상된 흡수를 갖는 경점막 전달 장치
US20090143362A1 (en) * 2007-12-04 2009-06-04 Barabde Umesh Vinayakrao Carbamazepine formulations
US9724362B2 (en) * 2007-12-06 2017-08-08 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US9233078B2 (en) 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
EP2744572B1 (en) 2011-08-18 2017-12-13 BioDelivery Sciences International, Inc. Abuse-resistant mucoadhesive devices for delivery of buprenorphine
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4431641A (en) * 1980-10-17 1984-02-14 Ciba-Geigy Corporation Pharmaceutical compositions having antiepileptic and antineuralgic action
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
US4553973A (en) * 1982-07-12 1985-11-19 Alza Corporation Process for preparing osmotic device
GB2150830B (en) * 1983-12-05 1987-08-19 Alza Corp Drug dispenser
US4716031A (en) * 1984-03-21 1987-12-29 Alza Corporation Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
US4685918A (en) * 1985-02-01 1987-08-11 Merck & Co., Inc. Lipid osmotic pump

Also Published As

Publication number Publication date
FI873409A (fi) 1988-02-08
NL194780C (nl) 2003-03-04
NO173726B (no) 1993-10-18
SE8703034D0 (sv) 1987-08-03
ZA875804B (en) 1988-02-08
NZ221347A (en) 1989-12-21
FI86143B (fi) 1992-04-15
PH25090A (en) 1991-02-19
DK410787A (da) 1988-02-08
NL194780B (nl) 2002-11-01
GR871234B (en) 1987-12-08
FR2602425A1 (fr) 1988-02-12
IL83386A (en) 1992-01-15
SE502590C2 (sv) 1995-11-20
IT1215618B (it) 1990-02-22
IL83386A0 (en) 1987-12-31
AU7661787A (en) 1988-02-11
JP2592460B2 (ja) 1997-03-19
GB8717643D0 (en) 1987-09-03
IE872110L (en) 1988-02-07
NO873298D0 (no) 1987-08-06
BE1000235A3 (fr) 1988-09-20
HK33793A (en) 1993-04-16
NL8701857A (nl) 1988-03-01
DE3725824C2 (de) 1998-12-17
DE3725824A1 (de) 1988-02-11
MY100767A (en) 1991-02-14
FI873409A0 (fi) 1987-08-05
KR880002511A (ko) 1988-05-09
GB2193632B (en) 1990-04-25
FI86143C (fi) 1992-07-27
GB2193632A (en) 1988-02-17
ATA199387A (de) 1993-08-15
IT8748270A0 (it) 1987-08-05
DK410787D0 (da) 1987-08-06
AU597403B2 (en) 1990-05-31
CA1302267C (en) 1992-06-02
JPS6344525A (ja) 1988-02-25
KR950006219B1 (ko) 1995-06-12
CH668187A5 (de) 1988-12-15
HUT44930A (en) 1988-05-30
DD285718A5 (de) 1991-01-03
LU86966A1 (fr) 1989-03-08
IE59718B1 (en) 1994-03-23
FR2602425B1 (fr) 1990-09-14
PT85489B (pt) 1990-06-29
DK175497B1 (da) 2004-11-15
PT85489A (en) 1987-09-01
US4857336A (en) 1989-08-15
SE8703034L (sv) 1988-02-08
NO173726C (no) 1994-01-26
HU206978B (en) 1993-03-01
AT397344B (de) 1994-03-25
ES2007100A6 (es) 1989-06-01

Similar Documents

Publication Publication Date Title
NO873298L (no) Oralt terapeutisk system med systematisk virkning.
DE3783437T2 (de) Heilmittel.
FI883757A (fi) Terapeutiska nukleosider.
FI881177A (fi) Anordning foer positionering av en patient i en medicinsk panoramaroentgenfotograferingsanordning.
FI894688A0 (fi) Flytande oralt tagbart terapeutiskt system.
FI881651A (fi) Terapeutiska nukleosider.
FI875098A0 (fi) Transdermalt terapeutiskt system.
FI884048A (fi) Foerfarande foer bestaemning av halten av en gaskomponent i en patients andningsluft.
FI875039A0 (fi) Terapeutiska sammansaettningar foer veterinaermedicinsk anvaendning.
FI860209A0 (fi) Engaongselektrod foer undersoekning av en patient.
FI902973A0 (fi) Magnetfaeltsgenerator foer terapeutiska aendamaol.
FI870980A (fi) Atomreaktor foersedd med i laengdriktningen laongstraeckt kaerl.
FI885441A0 (fi) Nya vaccin.
NO883976D0 (no) Medisinsk plaster.
FI865069A0 (fi) Terapeutiskt system.
FI864995A0 (fi) Med solenergi driven straolningsanordning foer medicinskt bruk.
FI881216A (fi) Terapeutiska nukleosider.
FI875616A (fi) Farmaceutiska blandningar.
FI875325A (fi) Bestraolningsanordning foer synbart ljus vid medicinal anvaendning.
DK125687A (da) Patientkran-chassis
FI880513A0 (fi) Anordning foer foeljande med en patients livsfunktioner.
FI871533A0 (fi) Daeck med infaellda dubbar.
FI861463A0 (fi) Stoedarrangemang foer patient vid en panoramaroentgenfotograferingsanordning.
FI851327A0 (fi) Vaendbaedd foer en patient.
FI871743A0 (fi) Vaendbaedd foer en patient.

Legal Events

Date Code Title Description
MK1K Patent expired